Before aortic root surgery, review the anatomy, timing, valve strategy, and full operative plan.

Aortic root surgery treats the part of the aorta attached to the heart, where the aortic valve and coronary arteries connect. Depending on the anatomy and valve, an operation may preserve the native valve, replace the root and valve together with a composite graft, and/or extend into the ascending aorta or arch. The exact scope should be clear before consent.

A second opinion can be useful when root surgery has been proposed, measurements are close to a decision threshold, studies disagree, valve-sparing and composite-graft approaches are both being discussed, or bicuspid valve disease, connective-tissue disease, coronary disease, arch involvement, or prior heart surgery makes the plan more complex. It should not delay urgent or time-sensitive care directed by your treating team.

No. The root and tubular ascending aorta are adjacent but distinct segments. Enlargement may involve one or both, and a proposed operation may extend across the root, ascending aorta, or arch. Source imaging and segment-specific measurements are needed to understand the actual anatomy and operative scope.

Valve-sparing root replacement replaces the diseased root while retaining the patient’s native aortic valve, sometimes with additional valve repair. A Bentall procedure replaces the root and valve together with a valved conduit and reconnects the coronary arteries. Each approach has anatomy, durability, prosthesis, follow-up, and experience considerations. The review explains those factors without selecting a procedure for you.

No. TAVR treats the aortic valve; it does not replace or repair an enlarged aortic root or ascending aorta. When valve disease and proximal-aorta enlargement coexist, the complete valve and aortic anatomy must be considered together. The treating team determines whether continued surveillance, open surgery, or another plan is appropriate.

Sometimes, but not for every valve or every patient. The discussion can depend on cusp tissue quality, bicuspid or tricuspid morphology, stenosis, the mechanism and severity of regurgitation, root geometry, whether cusp repair is needed, expected durability, and the surgeon’s valve-sparing experience. The treating surgical team determines technical candidacy.

Either may be considered, depending on the clinical situation. A mechanical valve is designed for long durability but generally requires lifelong anticoagulation. A tissue valve may avoid lifelong warfarin but can deteriorate and create future reintervention questions. Age, bleeding and clotting context, pregnancy considerations when relevant, lifestyle, and future options belong in shared decision-making.

A bicuspid valve can be associated with enlargement of the root or ascending aorta and may have stenosis, regurgitation, or cusp anatomy that affects preservation or replacement questions. A useful review considers the valve and the entire proximal aorta together rather than treating the diameter as the only issue.

Yes, when relevant and documented. A specific genetic diagnosis, syndromic features, age, body size, family history of aneurysm or dissection, pregnancy considerations, and prior genetic evaluation can change guideline context, operative questions, and surveillance. Current aortic-disease guidance also places imaging of first-degree relatives and genetic evaluation when indicated in the family conversation. For bicuspid aortic valve, transthoracic echocardiographic screening of first-degree relatives is recommended, with CT or MRI when the root or ascending aorta cannot be assessed completely by echo. Each relative should discuss personal screening with their own clinician.

Yes. Coronary disease, another valve problem, arch involvement, rhythm surgery, and prior cardiac operations can change the scope and risk of a root operation. The report organizes the complete proposed procedure so a root decision is not evaluated as if it were happening alone.

Root operations are technically complex, and different programs may have different experience with valve-sparing, composite-graft, arch, genetic-aortopathy, and redo cases. The review can organize procedure-specific experience, multidisciplinary aortic capability, and public outcomes when available. It does not guarantee a particular outcome or imply a hospital partnership.

The exact record depends on the case. It commonly includes source CT or MRI images and reports, serial imaging, echocardiogram images and reports, clinical and surgical notes, coronary assessment when relevant, laboratory results, medication and medical history, genetic or family context, and the proposed operative plan. The records team can help identify what is required.

A cardiac surgeon and cardiologist independently review the same complete record and co-sign one WHITEGLOVE Insights™ report. Both physician perspectives are included in both plans.

After your complimentary conversation, we email the package we recommend, what it includes, and the secure next step. The written review includes two independent physician reviews and a co-signed written report; higher service levels add a live consultation. WHITEGLOVEMD is direct-pay and does not submit an insurance claim.

The report is delivered within 24 hours only after all required records and imaging are received and confirmed complete. Time spent gathering missing records is outside the 24-hour window. Do not delay urgent or time-sensitive care while waiting for a second opinion.

No. WHITEGLOVEMD provides educational decision support and independent medical-record review. It does not diagnose, prescribe, select a procedure, perform surgery, establish a treating physician–patient relationship, provide emergency care, or replace the clinicians responsible for your care. The decision remains with you and your treating team.